Product Innovators
My ROI? A promising partnership — and no surprises.
"I've always turned to Thomson Reuters Pharma™ for help in finding new opportunities. Now I use it to find the right partner to develop those opportunities."
Jane used Thomson Reuters Pharma two years ago to identify a therapy area with an unmet need. Armed with extensive information, her company set out to develop a novel therapy with tremendous market potential.
After promising data from a Phase I trial, Jane needed to find a compatible licensing partner that could help develop the therapy further. So once again, Jane leveraged the vast — yet readily accessible — data in Thomson Reuters Pharma to search for partners who could be the right fit. With intuitive search and reporting tools, she could:
- Proactively identify potential partners by viewing their pipeline and seeing how it complements your own pipeline/particular drug for out-licensing
- View company profiles — areas of focus, financial state, drug pipeline, listing of partnerships, and drug licensing deals
- View drug profiles — drug discovery and development, patent protection, chemical structure, target/MOA, indications in development, and details on discovery stage, pre-clinical and clinical trials information
- View drug licensing deals, searchable by therapy area, stage of deal, and announced deal structures, providing comparisons for structuring deal terms
When a multi-million dollar licensing deal was hanging in the balance, Jane was confident Thomson Reuters Pharma had the best early stage pipeline information to help her to see where her compound might complement the pipeline of various potential partners. She was able to examine all of this comprehensive information in one place, prepared by industry experts at Thomson Reuters.
Pipeline. Deals. Companies. All from a single comprehensive source trusted by 100 PERCENT of the top 20 pharmaceutical companies. Now that's a smart investment.
Get More Information — WATCH OUR DEMO and get free report
Now you've seen what Thomson Reuters Pharma did for Jane, why not see some more of what Thomson Reuters Pharma can do for you and your business.
Simply fill out the form below in order to see a recorded video demonstration of Thomson Reuters Pharma. We'll also give you a new complimentary therapy area report, focusing on key market players and deals highlights in the Obesity area.

Feedback